Please use this identifier to cite or link to this item:
Title: A killed Leishmania vaccine with sand fly saliva extract and saponin adjuvant displays immunogenicity in dogs.
Authors: Giunchetti, Rodolfo Cordeiro
Oliveira, Rodrigo Corrêa de
Martins Filho, Olindo Assis
Carvalho, Andréa Teixeira de
Roatt, Bruno Mendes
Soares, Rodrigo Dian de Oliveira Aguiar
Vital, Wendel Coura
Abreu, Raquel Trópia de
Malaquias, Luiz Cosme Cotta
Gontijo, Nelder de Figueiredo
Brodskyn, Cláudia
Oliveira, Camila Indiani de
Costa, Dirceu Joaquim
Lana, Marta de
Reis, Alexandre Barbosa
Keywords: Canine visceral leishmaniasis
Cell and humoral immune response
Flow cytometry
Issue Date: 2008
Citation: GIUNCHETTI, R. C. et al. A killed Leishmania vaccine with sand fly saliva extract and saponin adjuvant displays immunogenicity in dogs. Vaccine, v. 26, n. 5, p. 623-638, jan. 2008. Disponível em: <>. Acesso em: 05 jul. 2012.
Abstract: A vaccine against canine visceral leishmaniasis (CVL), comprising Leishmania braziliensispromastigote protein, sand fly gland extract (SGE) and saponin adjuvant, was eval-uated in dog model, in order to analyse the immunogenicity of the candidate vaccine. The vaccine candidate elicited strong antigenicity in dogs in respect of specific SGE andLeishmania humoral immune response. The major saliva proteins recognized by serum from immunized dogs exhibited molecular weights of 35 and 45 kDa, and were related to the resistance pattern against Leishmaniainfection. Immunophenotypic analysis revealed increased circulating CD21 + B-cells and CD5 + T-cells, reflected by higher counts of CD4 + and CD8 + T-cells. The observed interac-tion between potential antigen-presenting cells (evaluated as CD14 + monocytes) and lymphocyte activation status indicated a relationship between innate and adaptive immune responses. The higher frequency in L. chagasi antigen-specific CD8 + T-lymphocytes, and their positive association with intense cell proliferation, in addition to the progressively higher production of serum nitric oxide levels, showed a profile compatible with anti-CVL vaccine potential. Further studies on immunological response after challenge with L. chagasi may provide important information that will lead to a better understanding on vaccine trial and efficacy.
ISSN: 0264410X
metadata.dc.rights.license: O periódico Vaccine concede permissão para depósito deste artigo no Repositório Institucional da UFOP. Número da licença: 3291401392425.
Appears in Collections:DEACL - Artigos publicados em periódicos

Files in This Item:
File SizeFormat 
ARTIGO_KilledLeishmaniaVaccine.pdf1,11 MBAdobe PDFView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.